ClinicalTrials.gg
Sign In

Death, Sudden, Cardiac clinical trials

The registry lists 363 studies for Death, Sudden, Cardiac across more than 10 countries. 84 are recruiting or about to start. 149 of them are mainly about Death, Sudden, Cardiac (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Death, Sudden, Cardiac studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
184
Recruiting
63
Status unknown
54
Terminated
18
Active, not recruiting
15
Not yet recruiting
13

Phase

Phase 3
22
Phase 4
11
Phase 2
11
Phase 1
7

Where

United States
112
Germany
43
France
27
Canada
26
United Kingdom
22
Italy
22

Who runs them

National Heart, Lung, and Blood Institute (NHLBI) (14) · Abbott Medical Devices (8) · University College, London (8) · Zoll Medical Corporation (7) · Johns Hopkins University (6) · Boston Scientific Corporation (6) · Medtronic Cardiac Rhythm and Heart Failure (6) · Technical University of Munich (4)

What is being tested here

Drugs under test in Death, Sudden, Cardiac studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Epinephrine101
Tideglusib101
Carvedilol101
Eleclazine012
Omega-3 fatty acid012
Amiodarone012
Mycophenolic Acid011
Lumacaftor001
Ivacaftor001
Regadenoson001

Drug classes tested here Beta blockers 1 open

Coming up

2phase 3 studies under way
22studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 63 Death, Sudden, Cardiac studies recruiting now, 41 (65%) set no upper age limit and 11 (17%) stop at 75 or younger. 21 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 7 (11%) take healthy volunteers.

Recruiting studies that take each age, of 63
AgeWomenMen
1015 (24%)15 (24%)
1861 (97%)61 (97%)
3060 (95%)60 (95%)
4057 (90%)57 (90%)
5057 (90%)57 (90%)
6556 (89%)56 (89%)
7554 (86%)54 (86%)
8547 (75%)47 (75%)

Across all 363 studies, recruiting or not: 16% stop at 75 or younger and 9% at 65; 24% take children; 1% are for women only and 3% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Death, Sudden, Cardiac studies take

Of 85 observational studies under Death, Sudden, Cardiac, half reached primary completion within 63 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase42 mo17–83 · 56 studies—42 mo22–86 · 47 studies
Observational63 mo40–… · 85 studies—74 mo42–… · 69 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 363. Browse all 363 → or search them.